Previous Close | 1.0000 |
Open | 0.8000 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 52.50 |
Expire Date | 2024-09-20 |
Day's Range | 0.8000 - 1.0000 |
Contract Range | N/A |
Volume | |
Open Interest | N/A |
(Bloomberg) -- Bank of America Corp. and BNP Paribas SA are on the verge of winning lead roles arranging Sanofi’s separation of its consumer-health business, according to people familiar with the matter, in one of the year’s most sought-after banking assignments. Most Read from BloombergIsrael Says a Cease-Fire Plan Backed by Hamas Falls Far ShortAt $2 Million Per Minute, Treasuries Mint Cash Like Never BeforeEx-Trump Controller Says Cohen Repaid From Personal AccountJack Dorsey Leaves Bluesky B
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript May 2, 2024 Regeneron Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $9.55 EPS, expectations were $10.17. Regeneron Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to […]
Q1 2024 Kymera Therapeutics Inc Earnings Call